SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ICU Medical, Inc. – ‘8-K’ for 8/8/22

On:  Monday, 8/8/22, at 4:18pm ET   ·   For:  8/8/22   ·   Accession #:  883984-22-39   ·   File #:  1-34634

Previous ‘8-K’:  ‘8-K’ on 5/18/22 for 5/17/22   ·   Latest ‘8-K’:  This Filing

Magnifying glass tilted right emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/08/22  ICU Medical, Inc.                 8-K:2,9     8/08/22   11:521K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     39K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    329K 
 6: R1          Cover Page                                          HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- icui-20220808_htm                   XML     21K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- icui-20220808_lab                     XML     67K 
 5: EX-101.PRE  XBRL Presentations -- icui-20220808_pre              XML     33K 
 3: EX-101.SCH  XBRL Schema -- icui-20220808                         XSD     10K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    16K 
11: ZIP         XBRL Zipped Folder -- 0000883984-22-000039-xbrl      Zip     40K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  icui-20220808  
 i false i ICU MEDICAL INC/DE i 000088398400008839842022-08-082022-08-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 FORM  i 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  i August 8, 2022

ICU MEDICAL, INC.

(Exact name of registrant as specified in its charter)
 i Delaware i 001-34634 i 33-0022692
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
 i 951 Calle Amanecer, i San Clemente, i California i 92673
(Address of principal executive offices)(Zip Code)

( i 949)  i 366-2183
Registrant's telephone number, including area code

N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 i Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
 i Common stock, par value $0.10 per share i ICUI i The Nasdaq Stock Market LLC
(Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  i 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 2.02. Results of Operations and Financial Condition

    On August 8, 2022, ICU Medical, Inc. issued a press release announcing its financial results for the second quarter of 2022. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated in Item 2.02 by reference.
     
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
Press release, dated August 8, 2022 announcing ICU Medical, Inc.'s second quarter 2022 earnings.
104Cover Page Interactive Data File (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
    ICU MEDICAL, INC.
Date: August 8, 2022  By: /s/ Brian M. Bonnell
   Brian M. Bonnell
   Chief Financial Officer and Treasurer



Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:8/8/22None on these Dates
 List all Filings 
Top
Filing Submission 0000883984-22-000039   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2022 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Sep. 26, 2:11:01.1am ET